Dementia presents a major societal challenge, with current diagnostic methods often lagging in accurately predicting disease progression. This project seeks to dress this gap by investigating the role of inflammation in dementia and its potential as a diagnostic and prognostic marker. By analysing targeted immune markers in blood samples, a wide array of other biomarkers, neuroimaging, socio-economic and demographic datapoints and combining them with standard diagnostic tools, such as cognitive assessments and brain imaging, we aim to improve early detection and prediction of dementia progression. This research holds promise in guiding personalised treatment approaches and ultimately improving outcomes for dementia patients.
